lunes, 24 de febrero de 2020

With data on lead drug, Kadmon and CEO Waksal plot their redemption

With data on lead drug, Kadmon and CEO Waksal plot their redemption

Morning Rounds

Shraddha Chakradhar

What to read around the web today

  • Rethinking clinical trials for next-generation cancer drugs. Knowable Magazine
  • Opioid settlement still elusive as some lawyers criticize it. Associated Press
  • With strong data on lead drug, Kadmon and CEO Harlan Waksal plot their redemption. STAT Plus
  • Hormone blocker shocker: Drug costs 8 times more when used for kids. Kaiser Health News
  • Emerson student with one of the world’s rarest diseases is heartened that the first drug to treat it could be approved soon. The Boston Globe

No hay comentarios: